115 related articles for article (PubMed ID: 16573784)
1. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea.
Jiang ZD; DuPont HL; Garey K; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M
Am J Gastroenterol; 2006 May; 101(5):1112-6. PubMed ID: 16573784
[TBL] [Abstract][Full Text] [Related]
2. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.
Jiang ZD; Okhuysen PC; Guo DC; He R; King TM; DuPont HL; Milewicz DM
J Infect Dis; 2003 Aug; 188(4):506-11. PubMed ID: 12898436
[TBL] [Abstract][Full Text] [Related]
4. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.
Garey KW; Jiang ZD; Ghantoji S; Tam VH; Arora V; Dupont HL
Clin Infect Dis; 2010 Dec; 51(12):1406-10. PubMed ID: 21058913
[TBL] [Abstract][Full Text] [Related]
5. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
6. Is the interleukin 8 promoter polymorphism rs4073/-251T >A associated with Clostridium difficile infection?
Miyajima F; Swale A; Zhang JE; Alfirevic A; Little M; Beeching NJ; Smith G; Kolamunnage-Dona R; Pirmohamed M
Clin Infect Dis; 2014 Jun; 58(12):e148-51. PubMed ID: 24633688
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
[TBL] [Abstract][Full Text] [Related]
10. Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism.
Rezazadeh M; Hajilooi M; Haidari M; Rafiei A; Alavi SA; Keramat F
Scand J Infect Dis; 2006; 38(11-12):1045-9. PubMed ID: 17148075
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
12. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of diarrhea at a university hospital and association with modifiable risk factors.
Garey KW; Graham G; Gerard L; Dao T; Jiang ZD; Price M; Dupont HL
Ann Pharmacother; 2006 Jun; 40(6):1030-4. PubMed ID: 16684806
[TBL] [Abstract][Full Text] [Related]
14. [A meta-analysis on interleukin-1 gene cluster polymorphism and genetic susceptibility for ankylosing spondylitis].
Wu Z; Gu JR
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):433-7. PubMed ID: 17459217
[TBL] [Abstract][Full Text] [Related]
15. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome.
Claudino M; Trombone AP; Cardoso CR; Ferreira SB; Martins W; Assis GF; Santos CF; Trevilatto PC; Campanelli AP; Silva JS; Garlet GP
J Leukoc Biol; 2008 Dec; 84(6):1565-73. PubMed ID: 18725394
[TBL] [Abstract][Full Text] [Related]
16. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
[TBL] [Abstract][Full Text] [Related]
18. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
